These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7817972)

  • 21. [The clinical and immunological correlations between the p24 antigenemia levels and those of anti-p24 antibodies in HIV-seropositive children].
    Apetrei C; Buzdugan I; Mitroi I; Duca M
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(2):141-4. PubMed ID: 7549257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
    J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The amount of early p24 antigenemia and not the time of first detection of virus predicts the clinical outcome of infants vertically infected with human immunodeficiency virus.
    Papaevangelou V; Pollack H; Riguad M; Arlievsky N; Lu ML; Rochford G; Krasinski K; Borkowsky W
    J Infect Dis; 1996 Mar; 173(3):574-8. PubMed ID: 8627019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
    Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
    J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening.
    Sickinger E; Jonas G; Yem AW; Goller A; Stieler M; Brennan C; Hausmann M; Schochetman G; Devare SG; Hunt JC; Kapprell HP; Bryant JD
    Transfusion; 2008 Apr; 48(4):584-93. PubMed ID: 18194389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
    Jackson JB; Kataaha P; Hom DL; Mmiro F; Guay L; Ndugwa C; Marum L; Piwowar E; Brewer K; Toedter G
    AIDS; 1993 Nov; 7(11):1475-9. PubMed ID: 8280414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody.
    Saville RD; Constantine NT; Cleghorn FR; Jack N; Bartholomew C; Edwards J; Gomez P; Blattner WA
    J Clin Microbiol; 2001 Jul; 39(7):2518-24. PubMed ID: 11427563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative relationship of circulating p24 antigen with human immunodeficiency virus (HIV) RNA and specific antibody in HIV-infected subjects receiving antiretroviral therapy. The RV43 Study Group.
    Brown AE; Vahey MT; Zhou SY; Chung RC; Ruiz NM; Hofheinz D; Lane JR; Mayers DL
    J Infect Dis; 1995 Oct; 172(4):1091-5. PubMed ID: 7561186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi.
    Weber B; Orazi B; Raineri A; Thorstensson R; Bürgisser P; Mühlbacher A; Areal C; Eiras A; Villaescusa R; Camacho R; Diogo I; Roth HJ; Zahn I; Bartel J; Bossi V; Piro F; Atamasirikul K; Permpikul P; Webber L; Singh S
    Clin Lab; 2006; 52(9-10):463-73. PubMed ID: 17078473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assay for simultaneous detection of HIV p24 antigen and anti-HIV antibody].
    Xu K; Zhang Y; Wang Y; Mbawuike I
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):377-9. PubMed ID: 12665911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group.
    Schüpbach J; Böni J; Tomasik Z; Jendis J; Seger R; Kind C
    J Infect Dis; 1994 Aug; 170(2):318-24. PubMed ID: 8035017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p24 antibody production in p24 antibody-negative HIV-infected subjects.
    Stickler MC; Sharpe S; Zolla-Pazner S
    Viral Immunol; 1992; 5(2):123-32. PubMed ID: 1616583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of p24 antigen in HIV testing.
    Mathews AA; Mambatta AK; Appalaraju B; Menon S
    Indian J Med Microbiol; 2016; 34(1):119. PubMed ID: 26776142
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.
    Sexton CJ; Costenbader EC; Vinh DT; Chen PL; Hoang TV; Lan NT; Feldblum P; Kim A; Giang le T
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):866-73. PubMed ID: 21936716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
    Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
    N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Virological diagnosis and follow-up of HIV infection. State of the art and situation in Tunisia].
    Ben Mamou M; Slim A; Garbouj M; Ben Redjeb S
    Tunis Med; 2006 Jul; 84(7):395-402. PubMed ID: 17039728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.